The association of diabetes with all-cause mortality in patients with end-stage renal disease compared to the general population in Poland - a comparative analysis

Waldemar Wierzba; Andrzej Śliwczyński; Waldemar Karnafel; Mariusz Gujski; Maciej Słodki; Aleksandra Lusawa; Jarosław Pinkas

doi:10.5114/aoms.2020.94955

The association of diabetes with all-cause mortality in patients with end-stage renal disease compared to the general population in Poland - a comparative analysis

Arch Med Sci. 2020 May 4;18(2):314-319. doi: 10.5114/aoms.2020.94955. eCollection 2022.

Authors

Waldemar Wierzba¹, Andrzej Śliwczyński¹, Waldemar Karnafel¹, Mariusz Gujski², Maciej Słodki³, Aleksandra Lusawa¹, Jarosław Pinkas⁴

Affiliations

¹ University of Humanities and Economics, Lodz, Poland.
² Medical University of Warsaw, Warsaw, Poland.
³ Department of Prenatal Cardiology in Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
⁴ Centre of Postgraduate Medical Education, Warsaw, Poland.

Abstract

Introduction: End-stage renal disease (ESRD) is an important complication of diabetes, which is the leading cause of ESRD worldwide. The aim of the study was a comparative analysis of all-cause mortality in patients with ESRD with diagnosed diabetes mellitus (DM) and no diagnosed DM.

Material and methods: Data for the analysis were obtained from the resources of the Polish National Health Fund, and they concerned patients with end-stage renal disease from the entire population of Polish patients in the period from 1.01.2011 to 31.12.2013. In addition, the period from 1.01.2012 to 31.12.2012 was analysed for two subpopulations: diabetic and non-diabetic patients.

Results: The all-cause mortality in patients with end-stage renal disease in Poland per 100,000 representatives of the general population was 17.7, 15.9, and 12.50 persons in 2011, 2012, and 2013, respectively. The all-cause mortality rates for patients with ESRD and diabetes in Poland in 2012 were more than 15 times higher, for both men and women, than the all-cause mortality rates for non-diabetic patients with ESRD. Mortality in the study group of diabetic men with ESRD amounted to 147.59 ±29.07/100,000 men, whereas in the study group of diabetic women with ESRD it was 105.13 ±26.77/100,000 women. Regarding non-diabetic men with ESRD and non-diabetic women with ESRD, mortality amounted to 9.58 ±6.29/100,000 and 6.87 ±2.27/100,000 men and women, respectively.

Conclusions: The occurrence of diabetes in patients with ESRD significantly increases the risk of death compared to patients with ESRD without diabetes.

Keywords: all-cause mortality; diabetes mellitus; end-stage renal disease.